CVS Health NYSE:CVS, a healthcare giant spanning insurance, pharmacy-benefit management and retail pharmacies, delivered another strong quarter on Wednesday, but Wall Street still hit the sell button as the stock fell 5.8% in regular trading. Adjusted earnings jumped to $2.58 per share from $1.81 a year ago, while revenue climbed 7.3% to $106.1 billion. Management also raised its 2026 adjusted earnings guidance to $7.90-$8.10 per share from $7.30-$7.50. On paper, that's exactly what investors want to see. In reality, the market had already moved on to what comes next.
The turnaround inside the business was hard to ignore. Adjusted operating income at the Health Care Benefits segment surged 85.5% to $2.43 billion as the medical benefit ratio improved to 87.4% from 89.9%, showing CVS is getting a much better grip on healthcare costs. Health Services revenue rose 11.5% to $51.8 billion, powered by stronger pharmacy demand and higher brand-drug pricing. Even better, management lifted its operating cash flow outlook to at least $11.5 billion from $9.5 billion after generating $10.59 billion in just the first six months of the year. That's a meaningful upgrade, although the company still warned that elevated medical costs and macro uncertainty haven't disappeared.
The problem wasn't 2026. It was 2027. Management's preliminary view of at least $8.44 in adjusted earnings per share next year has failed to excite investors who were hoping for a bigger number. That helps explain why a quarter packed with earnings beats, higher guidance and stronger cash generation still couldn't keep the stock in positive territory.

The GuruFocus chart reinforces another point. CVS now trades at $99.02 versus a GF Value of $77.71, putting the shares roughly 27.4% above their estimated fair value. In other words, the turnaround story isn't cheap anymore. Investors have already priced in a lot of good news, meaning CVS now has to keep delivering bigger earnings, stronger margins and sustained Aetna improvement if it wants the stock to keep climbing.